Search
Pharmacological Interventions
The use of medication to manage withdrawal symptoms, reduce cravings, or treat co-occurring mental health disorders e.g., methadone, buprenorphine, naltrexone.
A European Guide on Dual disorders: Health and Social Responses
Publication Date
Format
Guide
Themes
Treatment
Ancillary Services
Behavioural Therapy Interventions
Pharmacological Interventions
Recovery Support
Recovery-Oriented Services
Psychoactive Substances
Addiction
Quality Assurance
Best Practice Guidelines
Professional Development
Public Health
Mental Health
Resilience and Coping Strategies
Partner Organisation
This European guide by EUDA highlights the importance of addressing dual disorders, where mental health conditions and substance use disorders occur at the same time. These co-occurring conditions are common and often lead to poorer health...
GLP-1 RAs and Substance Use Disorder Treatment: The Potential and Emerging Challenges
Publication Date
Format
Leaflet, Infographic, Fact sheet, Poster
Themes
Treatment
Pharmacological Interventions
Psychoactive Substances
Addiction
| Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are revolutionizing the management of type 2 diabetes and obesity. Exciting new research suggests these medications may also hold immense promise for treating... |
Seasonal Variations in Treatment Seeking for Alcohol Use Disorder in the Total Danish Population
Publication Date
Format
Scientific article
Themes
Treatment
Ancillary Services
Pharmacological Interventions
Treatment Settings
A significant number of individuals with alcohol use disorder (AUD) do not seek treatment, and the factors influencing treatment-seeking behavior are not well understood. While it is known that alcohol consumption levels can fluctuate with...
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member